72.11.Z - Research and experimental development on biotechnology
46 - Wholesale trade, except of motor vehicles and motorcycles
47 - Retail trade, except motor vehicle retail
66 - Activities auxiliary to financial services and insurance activities
68 - Real estate activities
72 - Scientific research and development
86 - Human health activities
2020 | 2021 | 2022 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Gross profit (loss) | -0,1 | -0,3 | 0 | 100 |
EBITDA | -0,1 | -0,3 | 0 | 100 |
Short time liabilities | 14,4 | 14,8 | 14,8 | 0 |
Equity capital | -2 | -2,2 | -2,4 | -5,3 |
Operating profit (EBIT) | -0,1 | -0,3 | 0 | 100 |
Assets | 12,4 | 12,5 | 12,4 | -1 |
Net profit (loss) | -0,1 | -0,3 | 0 | 100 |
Cash | 12,2 | 12,4 | 12,2 | -1 |
Net income from sale | 0 | 0 | 0 | 0 |
Liabilities and provisions for liabilities | 14,4 | 14,8 | 14,8 | 0 |
Working assets | 12,4 | 12,5 | 12,4 | -1 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | 4,1 | 12,4 | 0 | -12,4 |
Equity capital to total assets | -15,8 | -17,9 | -19,1 | -1,2 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 2 147 483 648 | 2 147 483 648 | 2 147 483 648 | 0 |
Current financial liquidity indicator | 0.8632730841636658 | 0.8480648994445801 | 0.8399578332901001 | 0 |
Net dept to EBITDA | 13.281167030334473 | 4.891286373138428 | -8,4 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane